OncoLink at ASCO 1998: Monday May 18


CAF Slightly Improves Survival for High-Risk Localized Breast Cancer Patients
Canadian Study is First to Show Screening Reduces Prostate Cancer Deaths
Cancer Vaccine Triggers Immune System to Recognize Melanoma
Herpes Gene May Help Attack Prostate Cancer
Higher Doses of Paclitaxel Fail to Improve Survival Rates in Women with Metastatic Breast Cancer
Increased Frequency of Radiation Therapy Treatment for Small-Cell Lung Cancer Improves Survival Rates
New Agent Tested to Attack Blood Vessels that Feed Tumors
New Drug Expands Limited Treatment Arsenal for for Colorectal Cancer
Poor Understanding of Guidelines Results in Low National Use of Breast-Conserving Therapy
Raloxifene Reduces Incidence of Breast Cancer by 58-66% and May Reduce Risk of Endometrial Cancer in Postmenopausal Women
Single Treatment of Engineered Antibody Demonstrates 100 Percent Response Rate in Follicular Lymphoma
Study Finds that Elderly are Severely Underrepresented in Clinical Trials
Tamoxifen Reduces Breast Cancer Incidence by 45% in Women at High Risk of Developing the Disease
Taxol Use Results in Significant Survival Benefit When used in Adjuvant Setting for Node-Positive Breast Cancer Patients
Vinorelbine Plus Supportive Care Increases Survival and Quality of Life for Elderly Lung Cancer Patients
Vitamin A Derivative Effective in Treating Neuroblastoma


I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More